The novel approach of the medication represents a significant breakthrough in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatide-peptide639609.bloggazza.com/40680394/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment